Literature DB >> 23223600

Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection.

H S M Ammerlaan1, S Harbarth, A G M Buiting, D W Crook, F Fitzpatrick, H Hanberger, L A Herwaldt, P H J van Keulen, J A J W Kluytmans, A Kola, R S Kuchenbecker, E Lingaas, N Meessen, M M Morris-Downes, J M Pottinger, P Rohner, R P dos Santos, H Seifert, H Wisplinghoff, S Ziesing, A S Walker, M J M Bonten.   

Abstract

BACKGROUND: It is unknown whether rising incidence rates of nosocomial bloodstream infections (BSIs) caused by antibiotic-resistant bacteria (ARB) replace antibiotic-susceptible bacteria (ASB), leaving the total BSI rate unaffected.
METHODS: We investigated temporal trends in annual incidence densities (events per 100 000 patient-days) of nosocomial BSIs caused by methicillin-resistant Staphylococcus aureus (MRSA), ARB other than MRSA, and ASB in 7 ARB-endemic and 7 ARB-nonendemic hospitals between 1998 and 2007.
RESULTS: 33 130 nosocomial BSIs (14% caused by ARB) yielded 36 679 microorganisms. From 1998 to 2007, the MRSA incidence density increased from 0.2 to 0.7 (annual increase, 22%) in ARB-nonendemic hospitals, and from 3.1 to 11.7 (annual increase, 10%) in ARB-endemic hospitals (P = .2), increasing the incidence density difference between ARB-endemic and ARB-nonendemic hospitals from 2.9 to 11.0. The non-MRSA ARB incidence density increased from 2.8 to 4.1 (annual increase, 5%) in ARB-nonendemic hospitals, and from 1.5 to 17.4 (annual increase, 22%) in ARB-endemic hospitals (P < .001), changing the incidence density difference from -1.3 to 13.3. Trends in ASB incidence densities were similar in both groups (P = .7). With annual increases of 3.8% and 5.4% of all nosocomial BSIs in ARB-nonendemic and ARB-endemic hospitals, respectively (P < .001), the overall incidence density difference of 3.8 increased to 24.4.
CONCLUSIONS: Increased nosocomial BSI rates due to ARB occur in addition to infections caused by ASB, increasing the total burden of disease. Hospitals with high ARB infection rates in 2005 had an excess burden of BSI of 20.6 per 100 000 patient-days in a 10-year period, mainly caused by infections with ARB.

Entities:  

Mesh:

Year:  2012        PMID: 23223600     DOI: 10.1093/cid/cis1006

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  54 in total

Review 1.  Bloodstream infections in the Intensive Care Unit.

Authors:  Matteo Bassetti; Elda Righi; Alessia Carnelutti
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

Review 2.  The use of allogenic and autologous tissue to treat aortic valve endocarditis.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh; Mario Lusini; Antonio Nenna; Ivancarmine Gambardella; Massimo Chello
Journal:  Ann Transl Med       Date:  2019-09

Review 3.  Developments for improved diagnosis of bacterial bloodstream infections.

Authors:  A J M Loonen; P F G Wolffs; C A Bruggeman; A J C van den Brule
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-22       Impact factor: 3.267

Review 4.  Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients.

Authors:  Elisabeth Paramythiotou; Christina Routsi
Journal:  World J Crit Care Med       Date:  2016-05-04

5.  Unbiased Identification of Immunogenic Staphylococcus aureus Leukotoxin B-Cell Epitopes.

Authors:  David N Hernandez; Kayan Tam; Bo Shopsin; Emily E Radke; Pegah Kolahi; Richard Copin; François-Xavier Stubbe; Timothy Cardozo; Victor J Torres; Gregg J Silverman
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

Review 6.  Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria.

Authors:  Andre Arizpe; Kelly R Reveles; Shrina D Patel; Samuel L Aitken
Journal:  Curr Infect Dis Rep       Date:  2016-12       Impact factor: 3.725

7.  Assessment of Microbiota and Their Drug Resistance in Chronic Fistulous Tracts.

Authors:  Xiuwen Wu; Jianan Ren; Xiaoting Li; Song Liu; Qin Wu; Gefei Wang; Guosheng Gu; Huajian Ren; Jieshou Li
Journal:  Surg Infect (Larchmt)       Date:  2015-04-20       Impact factor: 2.150

8.  β-(1,3)-Glucan Unmasking in Some Candida albicans Mutants Correlates with Increases in Cell Wall Surface Roughness and Decreases in Cell Wall Elasticity.

Authors:  Sahar Hasim; David P Allison; Scott T Retterer; Alex Hopke; Robert T Wheeler; Mitchel J Doktycz; Todd B Reynolds
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

Review 9.  Implantable Device-Related Infection.

Authors:  J Scott VanEpps; John G Younger
Journal:  Shock       Date:  2016-12       Impact factor: 3.454

Review 10.  [Multiresistant gram-negative bacteria. A bacterial challenge of the twenty-first century].

Authors:  K Schröppel; R Riessen
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-03-13       Impact factor: 0.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.